IRIS
FERRERO, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 52.898
Totale 52.898
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 52.898
Totale 52.898
Salva come PNG Salva come JPEG
Città #
Genova 38.744
Rapallo 4.979
Genoa 4.593
Vado Ligure 4.453
Bordighera 129
Totale 52.898
Salva come PNG Salva come JPEG
Nome #
Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer 217
Microablative fractional CO2 laser improves dyspareunia related to vulvovaginal atrophy: a pilot study 183
Bowel preparation before laparoscopic gynaecological surgery in benign conditions using a 1-week low fibre diet: a surgeon blind, randomized and controlled trial. 175
Antiangiogenic therapies in endometriosis. 161
Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis 159
Ureteral Suspension Facilitates Surgery for Deep Pelvic Endometriosis 157
Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. 155
Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies 154
Post-operative complications after caesarean section in HIV-infected women. 154
The efficacy of 2002 CDC guidelines in preventing perinatal group B Streptococcal vertical transmission: a prospective study. 152
Multislice CT enteroclysis in the diagnosis of bowel endometriosis. 151
Triptorelin for the treatment of endometriosis. 151
What is the desired menstrual frequency of women without menstruation-related symptoms? 150
Outpatient periurethral injections of polyacrylamide hydrogel for the treatment of female stress urinary incontinence: effectiveness and safety. 150
Endometriotic ovarian cysts do not negatively affect the rate of spontaneous ovulation 150
Accuracy of intra-operative frozen section in the diagnosis of borderline ovarian tumors and clinical impact of underdiagnosis 148
The preoperative diagnosis of borderline ovarian tumors: a review of current literature 147
Urinary incontinence and bladder endometriosis: conservative management 146
Emostasi attraverso elettrocoagulazione con corrente bipolare oppure sutura laparoscopica dopo escissione chirurgica di endometriomi ovarici bilaterali: studio prospettico randomizzato 144
OC13.01: Intraoperative ultrasonography during laparoscopic myomectomy 144
Haptoglobin concentration in peritoneal fluid of women with endometriosis 143
Triptorelin improves intestinal symptoms among patients with colorectal endometriosis. 142
Maternal arrhythmias during pregnancy. 141
Periurethral injection of polyacrylamide hydrogel for the treatment of stress urinary incontinence: the impact on female sexual function. 141
Cardiovascular effects of antimuscarinic agents in overactive bladder 141
Unique Eomes+ NK cell subsets are present in uterus and decidua during early pregnancy 141
IL-27 induces the expression of IDO and PD-L1 in human cancer cells 141
Abdominal pain, bloating, and urgency. 141
Endometrial directed biopsy during sonohysterography using the NiGo device: prospective study in women with abnormal uterine bleeding. 140
Atherosclerosis in Women With Endometriosis. 140
The association between p53 expression, stage and histological features in endometrial cancer 140
Bowel endometriosis: CT-enteroclysis. 139
Drug safety evaluation of desogestrel 139
A Case of Large Uterine Myoma in a 14-Year-Old Girl 138
Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura 136
Abstract book of the 30th ESHRE Annual Meeting, Munich, Germany, 29 June - 2 July 2014 136
Vaginal sacrospinous colpopexy using the Capio suture-capturing device versus traditional technique: feasibility and outcome 136
Vascular endothelial growth factor, persistent disease, and survival in ovarian cancer. 135
Proteomics technologies in endometriosis 135
L'enteroclisi-TC multistrato del colon (E-TCMS) associata alla tecnica "split-bolus": metodica integrata per la valutazione degli ureteri in donne con endometriosi intestinale 135
Lateral distribution of benign ovarian cysts. 135
Desogestrel only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study 135
Future perspectives in the medical treatment of endometriosis. 135
Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review 135
Use of Neonatal Antiretroviral Prophylaxis for Prevention of Mother‐to‐Child Transmission of HIV Is Decreasing in Western Europe 134
Endometriosis and irritable bowel syndrome: co-morbidity or misdiagnosis? 134
Safety and efficacy of vaginal hysterectomy in the large uterus with the LigaSure bipolar diathermy system. 133
Bowel endometriosis: Recent insights and unsolved problems 133
Comparing treatments for endometriosis-related pain symptoms in patients with migraine without aura 133
Peritoneal carcinomatosis from primary malignant ovarian paraganglioma: a challenging management of an extremely rare case 133
Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients. 133
Cardiovascular Safety of β3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder Syndrome 132
Cardiovascular effects of antimuscarinic agents and beta3-adrenergic receptor agonist for the treatment of overactive bladder 132
Total and active ghrelin levels in women with polycystic ovary syndrome. 131
Intestinal Endometriosis: Mimicker of Inflammatory Bowel Disease? 131
Fertility after bowel resection for endometriosis. 131
Body mass index in endometriosis. 130
Deep dyspareunia: causes, treatments, and results. 130
Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies 130
Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis 130
Asthma in women with endometriosis 129
Aromatase and endometriosis: estrogens play a role 129
Endometriosis at 2nd surgery--residual or recurrent disease. 129
Vascular endothelial growth factor concentrations in serum of patients with extensive slow-flow vascular malformations. 129
Proteomic analysis of peritoneal fluid in women with endometriosis. 128
Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel-releasing intrauterine device 128
HCV vertical transmission: long-term prospective study 128
Imidafenacin for the treatment of overactive bladder 128
Multidetector computerized tomography enema versus magnetic resonance enema in the diagnosis of rectosigmoid endometriosis 128
Bevacizumab for the treatment of cervical cancer 128
The involvement of the interstitial Cajal cells and the enteric nervous system in bowel endometriosis. 127
How complete is full thickness disc resection of bowel endometriotic lesions? A prospective surgical and histological study 127
Preoperative treatment with letrozole in patients undergoing laparoscopic myomectomy of large uterine myomas: a prospective non-randomized study 127
Current state of the art and emerging pharmacotherapy for uterine leiomyosarcomas 127
HCV vertical transmission: long-term prospective study 126
Investigational drugs for the treatment of endometriosis, an update on recent developments 126
MDCT Enteroclysis Urography With Split-Bolus Technique Provides Information on Ureteral Involvement in Patients With Suspected Bowel Endometriosis 126
Bevacizumab in endometrial cancer treatment 125
Transvaginal ultrasonography combined with water-contrast in the rectum in the diagnosis of rectovaginal endometriosis infiltrating the bowel. 125
Assessment of Myometrial and Cervical Invasion in Endometrial Cancer by Magnetic Resonance Imaging and 2D, 3D and HDlive Ultrasonography 125
Atomic force microscopy: a promising aid in diagnosis of uterine smooth muscle neoplasms 125
Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura. 125
Fetal risks related to the treatment of multiple sclerosis during pregnancy and breastfeeding. 124
Atherosclerosis in women with endometriosis. 124
"Triple marker" for ectopic pregnancy. 123
Defective placental adhesion in voluntary termination of second-trimester pregnancy and risk of recurrence in subsequent pregnancies. 123
Aromatase inhibitors in the treatment of bladder endometriosis 123
Migraine in women with endometriosis. 123
Ki-67, bcl-2, and M30 CytoDEATH in endometriotic lesions. 123
Changes in Sexual Function after Medical or Surgical Termination of Pregnancy 123
Proteomic patterns in plasma and peritoneal fluid of women with endometriosis. 123
Proteomics technologies in endometriosis. 122
Vaginal danazol in women with rectovaginal endometriosis and pain symptoms persisting after the insertion of the levonorgestrel-releasing intrauterine device. 122
Asthma in women with endometriosis. 122
Endometriosis presenting with hemorrhagic ascites 122
VEGF levels in patients with peripheral arterial occlusive disease receiving LDL-apheresis. 121
Dienogest in the treatment of endometriosis. 121
Advances in pharmacotherapy for treating endometriosis 121
Uterine myomas, dyspareunia, and sexual function. 121
Aromatase and endometriosis: estrogens play a role 120
Totale 13.574
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.622
article - articoli 128.236
book - libri 355
conference - conferenze 33.666
curatela - curatele 0
other - altro 980
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.385
Totale 333.244
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.860 0 0 0 0 0 0 2.175 971 1.261 2.399 1.474 580
2020/20213.930 219 394 441 319 298 354 203 329 354 416 304 299
2021/20226.812 219 387 460 851 291 436 492 1.620 304 627 259 866
2022/20236.145 662 361 103 554 953 1.054 48 435 1.098 44 728 105
2023/20243.332 180 486 121 430 249 489 187 218 207 123 187 455
2024/20254.971 383 1.006 411 675 1.402 1.073 21 0 0 0 0 0
Totale 53.800